A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis

Clinical trial NCT02273817 · COMPLETED

Trial details

NCT number: NCT02273817
Sponsor: Apotex Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2011-03-01
Primary completion: 2011-08-01
Enrollment: 580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.